×
返回 Agenda
Closing Remarks
Session Chair(s)
Megan Doyle, JD, MPH
Associate Vice President, Assistant General Counsel - Diagnostics
Eli Lilly & Company, United States
Shyreen Kamal, PharmD
Manager, Scientific Programs
DIA, United States
Closing Remarks